| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |